Delivery Order SPE2DB22D2214-SPE2DB24FS2WS
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,685.40, is a firm-fixed-price delivery order with a completion date of February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $3,138.17 firm fixed-price delivery order for 4,560,123,368 units of the drug Ondansetron ODT 4 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of March 3, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,455.02 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets. The contract has a completion date of November 8, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,489.39, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,752.72 firm fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ondansetron ODT 4 mg tablets. The contract, valued at $1,927.30, is a firm-fixed price delivery order that runs through December 20, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,872.79 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of December 6, 2023 and was awarded on December 5, 2023 with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,564,514,283 units of Ondansetron ODT 4 mg tablets. The $6,434.62 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on May 6, 2024, with a completion date of May 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, valued at $22,448.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets to support military healthcare programs. It is a firm-fixed-price delivery order with an ultimate completion date of April 28, 2023. The contract was awarded through full and open competition, without any set-aside designation. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, with a ceiling value of $46,764.88 and a completion date of September 28, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS2WSDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets. The $3,478.99 contract is a firm fixed-price delivery order with an ultimate completion date of December 7, 2023. The award has no set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026 and covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare globally. Amerisourcebergen also has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/6/23 |